摘要
潜伏膜蛋白1作为人类疱疹病毒4型编码的产物,与各种肿瘤的发生、发展关系密切,但与血液肿瘤相关报道较少见.文章重点就潜伏膜蛋白1与血液肿瘤的相关性及治疗进展作一综述.
Latent membrane protein 1(LMP1)as a product of human herpesvirus 4 encoding is closely related to the occurrence and development of various tumors.However,the articles related to hematological tumors are rare.This review focuses on the correlation between LMP1 and hematological tumors and the progress of treatment.
作者
刘飞飞
沈建箴
Liu Feifei;Shen Jianzhen(Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China)
出处
《白血病．淋巴瘤》
CAS
2019年第7期441-444,共4页
Journal of Leukemia & Lymphoma
基金
福建省医学创新项目(2017-CX-16)
高效产学研合作项目(2018Y4004)
福建省血液医学中心项目(闽政办201704).
关键词
血液肿瘤
疱疹病毒4型
人
潜伏膜蛋白1
Hematologic neoplasms
Herpesvirus 4,human
Latent membrane protein 1
